Novel therapeutic targets in rheumatoid arthritis: Trends in Pharmacological Sciences
JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib | Annals of the Rheumatic Diseases
Molecular mode of action of Janus activated kinase (JAK) inhibitors.... | Download Scientific Diagram
Tofacitinib shows promise in PsA trials | Nature Reviews Rheumatology
Tofacitinib has a unique multitiered mechanism of action with an early... | Download Scientific Diagram
References in JAK inhibitors in 2019, synthetic review in 10 points - European Journal of Internal Medicine
Tofacitinib inhibits inflammatory cytokines from ulcerative colitis and healthy mucosal explants and is associated with pSTAT1/3 reduction in T-cells | American Journal of Physiology-Gastrointestinal and Liver Physiology
Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases | SpringerLink
Figure 2 from The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. | Semantic Scholar
Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients?
JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines | American Journal of Physiology-Gastrointestinal and Liver Physiology
Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach | Nature Reviews Rheumatology
Current and future status of JAK inhibitors - The Lancet
The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions - Journal of Allergy and Clinical Immunology
Selectivity of Janus Kinase Inhibitors in Rheumatoid Arthritis and Other Immune-Mediated Inflammatory Diseases: Is Expectation the Root of All Headache? | SpringerLink
IJMS | Free Full-Text | Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis | HTML
Oral Tofacitinib: Contemporary Appraisal of Its Role in Dermatology. - Abstract - Europe PMC
Xeljanz XR (tofacitinib citrate) Modified Release Tablets For the Treatment of Rheumatoid Arthritis - Clinical Trials Arena
Pharmaceuticals | Free Full-Text | Jakinibs of All Trades: Inhibiting Cytokine Signaling in Immune-Mediated Pathologies | HTML
Profile of Tofacitinib in the Treatment of Ulcerative Colitis: An Evid | DDDT
Efficacy of tofacitinib treatment in ulcerative colitis - ScienceDirect
Tofacitinib in ulcerative colitis | Immunotherapy
The emerging safety profile of JAK inhibitors in rheumatic disease | Nature Reviews Rheumatology
Guideline review: Tofacitinib for adults with moderately to severely active ulcerative colitis - NICE guidance | Frontline Gastroenterology
JAK Inhibitors in Rheumatoid Arthritis: An Evidence-Based Review on th | JIR
Figure 3 from The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. | Semantic Scholar
